The realignment reflected: Manufacturer rebate negotiations between Caremark, Novo Nordisk, and Eli Lilly Strategic positioning by both manufacturers competing for PBM preferred status Ongoing supply considerations (semaglutide moved off shortage status in October 2024) Clinical evidence accumulating from SELECT and SURMOUNT trials For members affected by the changes: New Wegovy prescriptions face fewer step-therapy barriers on templates that elevated Wegovy Existing Zepbound users on affected templates faced potential switch pressure The opposite occurred on different templates that preferred Zepbound Caremark's specific template assignments are not always transparent to members
If you are on a low-sodium diet or have high blood pressure or kidney problems, consult your doctor before using this method
Peripheral Neuropathy Caused by a B12 Deficiency All of your nerves that are not inside your brain or spinal cord are considered peripheral nerves
We know these medications are life-changing for patients. But doctors say there are a few nuances to keep in mind, including that this coverage is not permanent
Food and Drug Administration (FDA) recently flagged concerns about unapproved products labeled as for research use only but sold directly to consumers, many claiming the same GLP-1-based magic
An older 1996 study reported a half-life of around 6669 hours after an oral dose, which is dramatically longer